Antimicrobial Resistance Surveillance Market Trends
The increasing prevalence of infectious diseases is a significant driver for the antimicrobial resistance (AMR) surveillance industry. As, infectious diseases become more prevalent, there is a greater need for effective treatment. This often leads to increased use of antimicrobial drugs, leading to the likelihood of the development of antimicrobial resistance.
- For instance, according to the Centers for Disease Control and Prevention, the number of visits to physician offices for infectious and parasitic diseases increased to 10.2 million.
- Further, infectious diseases with antimicrobial-resistant strains pose a significant public health threat. They can spread more easily and widely, leading to outbreaks and even pandemics. Thus, surveillance is crucial for detecting these resistant strains early, allowing for timely responses such as targeted interventions and infection control measures.
- Moreover, antimicrobial resistance increases the economic burden on healthcare systems. As, treating infections with resistant strains often requires more expensive and complex therapies, and molecular diagnostics. Therefore, surveillance helps in optimizing treatment regimens, reducing unnecessary antibiotic prescriptions, and ultimately saving healthcare costs, thereby augmenting the market growth.